Statement on the fourteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic

Linda Rider

The WHO Director-Standard has the satisfaction of transmitting the Report of the fourteenth conference of the Worldwide Well being Polices (2005) (IHR) Unexpected emergency Committee pertaining to the coronavirus 2019 sickness (COVID-19) pandemic, held on Friday 27 January 2023, from 14:00 to 17:00 CET. The WHO Director-Common concurs with the […]

Role of Alternative Medical Systems in Adult Chronic Kidney Disease Patients: A Systematic Review of Literature

Linda Rider

Chronic kidney disease (CKD) is one of the leading causes of death globally, which affects 13.4{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} of the world’s population [1]. With deterioration in renal function, this leads to the onset of CKD-related complications, such as uremia, anemia, and electrolyte disorders [2]. These complications often manifest as symptoms ranging from pruritus, pain, and […]

9 Tips For Lowering Your Risk of Heart Disease

Linda Rider

Among Americans, heart disease is the leading cause of death. Someone has a heart attack every 40 seconds in the US. While heart disease statistics are scary, heart disease, generally speaking, is preventable for those who don’t have preexisting heart conditions.  However, there are challenges and several risk factors that […]

A New Study Links COVID-19 With This Debilitating Disease

Linda Rider

New investigation posted in the Nature Cardiovascular Investigation journal has joined postural orthostatic tachycardia syndrome (POTS for short) with COVID-19 an infection. The examine confirms the relationship between the two diseases, which had been observed by several cardiologists, together with Aneesh Tolat, MD, a cardiac electrophysiologist with the Hartford Health […]

LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized Music Treatment for Alzheimer’s Disease | News

Linda Rider

TORONTO–(Business enterprise WIRE)–Jun 2, 2022– 12.7 million People aged 65 and more mature are projected to have Alzheimer’s dementia by 2050. LUCID and JT are now partnering on the advancement of a prescription electronic therapeutic for Alzheimer’s sickness. Alzheimer’s is far more than just memory loss – neuropsychiatric signs and […]

Subscribe US Now